1. Home
  2. CLDX vs HDL Comparison

CLDX vs HDL Comparison

Compare CLDX & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • HDL
  • Stock Information
  • Founded
  • CLDX N/A
  • HDL 2016
  • Country
  • CLDX United States
  • HDL Singapore
  • Employees
  • CLDX N/A
  • HDL N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HDL Restaurants
  • Sector
  • CLDX Health Care
  • HDL Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • HDL Nasdaq
  • Market Cap
  • CLDX 1.3B
  • HDL 1.6B
  • IPO Year
  • CLDX 2008
  • HDL 2024
  • Fundamental
  • Price
  • CLDX $16.85
  • HDL $22.93
  • Analyst Decision
  • CLDX Buy
  • HDL
  • Analyst Count
  • CLDX 8
  • HDL 0
  • Target Price
  • CLDX $54.29
  • HDL N/A
  • AVG Volume (30 Days)
  • CLDX 767.1K
  • HDL 5.2K
  • Earning Date
  • CLDX 05-05-2025
  • HDL 05-20-2025
  • Dividend Yield
  • CLDX N/A
  • HDL N/A
  • EPS Growth
  • CLDX N/A
  • HDL N/A
  • EPS
  • CLDX N/A
  • HDL 0.04
  • Revenue
  • CLDX $7,020,000.00
  • HDL $778,308,000.00
  • Revenue This Year
  • CLDX N/A
  • HDL $19.06
  • Revenue Next Year
  • CLDX $27.01
  • HDL $13.52
  • P/E Ratio
  • CLDX N/A
  • HDL $67.78
  • Revenue Growth
  • CLDX 1.99
  • HDL 13.20
  • 52 Week Low
  • CLDX $16.75
  • HDL $13.94
  • 52 Week High
  • CLDX $47.00
  • HDL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 29.79
  • HDL N/A
  • Support Level
  • CLDX $19.48
  • HDL N/A
  • Resistance Level
  • CLDX $20.38
  • HDL N/A
  • Average True Range (ATR)
  • CLDX 1.03
  • HDL 0.00
  • MACD
  • CLDX -0.17
  • HDL 0.00
  • Stochastic Oscillator
  • CLDX 2.19
  • HDL 0.00

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan.

Share on Social Networks: